Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Prescription Drug Affordability Board presents business cases; committee seeks savings offsets and retains repeal bill for study
Summary
Division III said the Prescription Drug Affordability Board provided three draft business cases — Medicare reference pricing, Humira biosimilar substitution and a discount-card initiative — and the committee adjusted PDAB funding downward while allowing a small non-lapsing carry-forward to cover contract timing.
Republican leaders told Division III they had worked with the Prescription Drug Affordability Board (PDAB) over the weekend and received three business-case documents that appear to justify continuing the board's baseline spending.
The PDAB presented business cases for (1) using Medicare reference pricing to lower state purchases for some drugs, (2) encouraging biosimilar uptake for high-cost biologics such as Humira, and (3) operating a discount…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
